[Combined behavioural and neuroscientific insights can improve anti-tobacco strategies]
Alice Soriano1, Dorothée Rieu, Olivier Oullier
1Laboratoire de psychologie cognitive (UMR 7290), Fédération de recherche comportement cerveau cognition (FR 3512), Aix-Marseille université et CNRS, 3, place Victor Hugo, 13331 Marseille Cedex 3, France - Mediamento, Institut d'études cognitives des médias et de la publicité, Paris, France.
Abstract:
In France, cognitive science (e.g., eye-tracking) and neuroscience (e.g., functional neuroimaging) are not used to develop and test anti-tobacco strategies. The newly found knowledge in behavioral and brain sciences could provide valuable insights in the understanding of attentional, emotional, memorization and decision-making processes at play when tobacco addicts are exposed to prevention messages. We argue that neuroscientific methods should be used in the fight against tobacco to better design and evaluate the impact of measures such as combined text and graphic (shock) warnings, neutral packets and support to people who want to stop smoking.
More Related Videos
14:21Creating Dynamic Images of Short-lived Dopamine Fluctuations with lp-ntPET: Dopamine Movies of Cigarette Smoking
Published on: August 6, 2013
08:47Spectral Confocal Imaging of Fluorescently tagged Nicotinic Receptors in Knock-in Mice with Chronic Nicotine Administration
Published on: February 10, 2012
Related Concept Videos
CNS Depressants: Alcohol and Nicotine
Stimulants
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
Drug Abuse and Addiction: Pharmacological Phenomena
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Stress Prevention and Stress Management Techniques IV
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
